Display options
Cite
de Groot JS, van Diest PJ, van Amersfoort M, et al. Intraductal cisplatin treatment in a . Oncotarget. 2017;8(37):60750-60763doi: 10.18632/oncotarget.18490.
de Groot, J. S., van Diest, P. J., van Amersfoort, M., Vlug, E. J., Pan, X., Ter Hoeve, N. D., Rosing, H., Beijnen, J. H., Youssef, S. A., de Bruin, A., Jonkers, J., van der Wall, E., & Derksen, P. W. B. (2017). Intraductal cisplatin treatment in a . Oncotarget, 8(37), 60750-60763. https://doi.org/10.18632/oncotarget.18490
de Groot, Jolien S, et al. "Intraductal cisplatin treatment in a ." Oncotarget vol. 8,37 (2017): 60750-60763. doi: https://doi.org/10.18632/oncotarget.18490
de Groot JS, van Diest PJ, van Amersfoort M, Vlug EJ, Pan X, Ter Hoeve ND, Rosing H, Beijnen JH, Youssef SA, de Bruin A, Jonkers J, van der Wall E, Derksen PWB. Intraductal cisplatin treatment in a . Oncotarget. 2017 Jun 15;8(37):60750-60763. doi: 10.18632/oncotarget.18490. eCollection 2017 Sep 22. PMID: 28977823; PMCID: PMC5617383.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Jun 15;8(37):60750-60763. doi: 10.18632/oncotarget.18490. eCollection 2017 Sep 22.

Intraductal cisplatin treatment in a .

Oncotarget

Jolien S de Groot, Paul J van Diest, Miranda van Amersfoort, Eva J Vlug, Xiaojuan Pan, Natalie D Ter Hoeve, Hilde Rosing, Jos H Beijnen, Sameh A Youssef, Alain de Bruin, Jos Jonkers, Elsken van der Wall, Patrick W B Derksen

Affiliations

  1. Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
  2. Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  3. Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  4. Department of Pathobiology, Dutch Molecular Pathology Center, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  5. Department of Pediatrics, Division of Molecular Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  6. Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  7. Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 28977823 PMCID: PMC5617383 DOI: 10.18632/oncotarget.18490

[No abstract available.]

Keywords: BRCA; breast cancer; cisplatin; intraductal; olaparib

Conflict of interest statement

CONFLICTS OF INTEREST The author(s) declare that they have no competing interests.

References

  1. Nat Cell Biol. 2014 Oct;16(10):942-50, 1-7 - PubMed
  2. N Engl J Med. 2002 May 23;346(21):1609-15 - PubMed
  3. Cancer Res. 2006 Jan 15;66(2):638-45 - PubMed
  4. J Clin Oncol. 2011 May 1;29(13):1664-9 - PubMed
  5. J Pharmacol Exp Ther. 2005 Sep;314(3):1052-8 - PubMed
  6. Gynecol Oncol. 2013 Dec;131(3):744-52 - PubMed
  7. PLoS Genet. 2013;9(3):e1003173 - PubMed
  8. JAMA. 2010 Sep 1;304(9):967-75 - PubMed
  9. Sci Transl Med. 2011 Oct 26;3(106):106ra108 - PubMed
  10. PLoS Genet. 2013;9(3):e1003212 - PubMed
  11. Breast Cancer Res Treat. 2005 May;91(1):29-34 - PubMed
  12. Cancer Prev Res (Phila). 2013 Jan;6(1):51-8 - PubMed
  13. Exp Toxicol Pathol. 2012 May;64(4):321-32 - PubMed
  14. Breast Cancer Res Treat. 2014 Sep;147(2):401-5 - PubMed
  15. Toxicol Pathol. 2010 Dec;38(7 Suppl):5S-81S - PubMed
  16. N Engl J Med. 2004 Jul 29;351(5):427-37 - PubMed
  17. Nature. 2011 Oct 09;479(7372):189-93 - PubMed
  18. Acta Oncol. 1995;34(6):771-7 - PubMed
  19. J Cell Biol. 2007 Jan 1;176(1):19-26 - PubMed
  20. Ann Surg. 2010 Mar;251(3):488-92 - PubMed
  21. JAMA. 2004 Sep 15;292(11):1317-25 - PubMed
  22. J Clin Oncol. 2005 Nov 20;23(33):8469-76 - PubMed
  23. Stem Cell Rev. 2012 Sep;8(3):982-93 - PubMed
  24. Cancer Res. 1996 Apr 1;56(7):1564-70 - PubMed
  25. Lancet. 2005 May 21-27;365(9473):1769-78 - PubMed
  26. Clin Breast Cancer. 2013 Aug;13(4):280-6 - PubMed
  27. N Engl J Med. 2009 Jul 9;361(2):123-34 - PubMed
  28. Br J Cancer. 2012 Jun 26;107(1):24-30 - PubMed
  29. Lancet. 2010 Jul 24;376(9737):235-44 - PubMed
  30. Breast Cancer Res Treat. 2012 Aug;135(1):201-8 - PubMed
  31. BMC Clin Pharmacol. 2008 Sep 17;8:7 - PubMed
  32. Gynecol Oncol. 2016 Feb;140(2):199-203 - PubMed
  33. Genes Dev. 2014 Jun 1;28(11):1143-58 - PubMed
  34. J Clin Oncol. 2015 Jan 20;33(3):244-50 - PubMed
  35. JAMA. 2001 Nov 14;286(18):2251-6 - PubMed
  36. Cell Death Differ. 2005 Jun;12(6):592-602 - PubMed
  37. Cell Cycle. 2004 Nov;3(11):1451-6 - PubMed
  38. Cell Stem Cell. 2010 Sep 3;7(3):403-17 - PubMed
  39. Lancet Oncol. 2011 Sep;12(9):852-61 - PubMed
  40. Nature. 2014 Feb 20;506(7488):322-7 - PubMed
  41. N Engl J Med. 2002 May 23;346(21):1616-22 - PubMed
  42. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12111-6 - PubMed
  43. Cancer Chemother Pharmacol. 1991;27(5):347-53 - PubMed
  44. J Clin Oncol. 2004 Mar 15;22(6):1055-62 - PubMed
  45. J Clin Oncol. 2010 May 20;28(15):2512-9 - PubMed
  46. Lancet. 2000 Mar 25;355(9209):1075-6 - PubMed
  47. Dis Model Mech. 2011 May;4(3):347-58 - PubMed
  48. J Mass Spectrom. 2006 Sep;41(9):1186-94 - PubMed
  49. Breast J. 2012 Sep;18(5):436-42 - PubMed
  50. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12117-22 - PubMed
  51. J Clin Oncol. 2007 Oct 1;25(28):4370-8 - PubMed
  52. Nat Med. 2009 Aug;15(8):907-13 - PubMed
  53. J Biol Chem. 2000 Aug 4;275(31):23899-903 - PubMed
  54. Nature. 2005 Apr 14;434(7035):917-21 - PubMed
  55. Lancet. 2010 Jul 24;376(9737):245-51 - PubMed
  56. Oncotarget. 2016 Apr 26;7(17):24778-91 - PubMed
  57. J Clin Oncol. 2013 Oct 20;31(30):3807-14 - PubMed
  58. J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):211-25 - PubMed
  59. Clin Cancer Res. 2009 Feb 15;15(4):1259-68 - PubMed
  60. Br J Cancer. 2003 Apr 22;88(8):1285-91 - PubMed

Publication Types